Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Influenza With Pneumonia”

71 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 71 results

Testing effectiveness (Phase 2)Study completedNCT04961541
What this trial is testing

Evaluation of the Safety and Immunogenicity of Influenza and COVID-19 Combination Vaccine

Who this might be right for
SARS-CoV InfectionCovid19
Novavax 637
Large-scale testing (Phase 3)Study completedNCT05047770
What this trial is testing

A Study on the Immune Response and Safety of the Shingles Vaccine and the Influenza Vaccine When Either is Given to Healthy Adults at the Same Time or Following a COVID-19 Booster Vaccine

Who this might be right for
Herpes Zoster
GlaxoSmithKline 2,013
Not applicableActive Not RecruitingNCT05160636
What this trial is testing

Look at the Health Outcomes of Patients With COVID-19 and Influenza

Who this might be right for
COVID-19Coronavirus Disease 2019Influenza
Pfizer 999
Large-scale testing (Phase 3)Study completedNCT06279871
What this trial is testing

Immunogenicity and Safety Study of Self-amplifying mRNA COVID-19 Vaccine Administered With Influenza Vaccines in Adults

Who this might be right for
COVID-19
Arcturus Therapeutics, Inc. 1,514
Large-scale testing (Phase 3)Not Yet RecruitingNCT07351500
What this trial is testing

Adaptive RCT of Corticosteroids for Severe Influenza Pneumonia in Adults

Who this might be right for
Influenza
Qingyuan Zhan 496
Not applicableLooking for participantsNCT06848309
What this trial is testing

Dissecting Human Immune Responses to Infection With Influenza or SARS-CoV-2

Who this might be right for
InfluenzaSARS-CoV-2 (COVID-19) InfectionImmune Response of Host
Washington University School of Medicine 300
Testing effectiveness (Phase 2)Ended earlyNCT01924169
What this trial is testing

Lenalidomide as Immune Adjuvant in Patient's With Chronic Lymphocytic Leukemia (CLL)

Who this might be right for
Hematologic Disorder
M.D. Anderson Cancer Center 3
Early research (Phase 1)Active Not RecruitingNCT04896853
What this trial is testing

Treatment of Respiratory Complications Associated With COVID19,Influenza ,Metapneumovirus,RSV Infection Using ProTrans®

Who this might be right for
COVID-19 Acute Respiratory Distress SyndromeInfluenza AMetapneumovirus Pneumonia+1 more
NextCell Pharma Ab 9
Not applicableStudy completedNCT05087355
What this trial is testing

Health Status Prior and Post Infection With Influenza or COVID 19: a Population Based Retrospective Analysis of 2016-2021

Who this might be right for
Covid 19Influenza
Medical University of Vienna 440,000
Testing effectiveness (Phase 2)Looking for participantsNCT06599658
What this trial is testing

COVID-19 Booster and IIV Schedule in Immunocompromised Hosts

Who this might be right for
COVID 19InfluenzaRheumatoid Arthritis (RA)+5 more
McGill University Health Centre/Research Institute of the McGill University Health Centre 660
Large-scale testing (Phase 3)UnknownNCT03900988
What this trial is testing

Intravenous N-acetylcysteine and Oseltamivir Versus Oseltamivir in Adults Hospitalized With Influenza and Pneumonia

Who this might be right for
Influenza
Chinese University of Hong Kong 160
Large-scale testing (Phase 3)Study completedNCT05310084
What this trial is testing

Safety and Immunogenicity of BNT162b2 Coadministered With SIIV in Adults 18 Through 64 Years of Age

Who this might be right for
SARS-CoV-2 InfectionCOVID-19
BioNTech SE 1,134
Post-approval studies (Phase 4)Study completedNCT05499351
What this trial is testing

Booster Immunization With COVID-19 Vaccine,Inactivated Co -Administration With Influenza Vaccine and Pneumococcal Polysaccharide Vaccine

Who this might be right for
COVID-19
Sinovac Biotech Co., Ltd 3,000
Large-scale testing (Phase 3)UnknownNCT06175468
What this trial is testing

Evaluate the Efficacy and Safety of "Formosa 1-Breath Free (NRICM101) " in Subjects With the Symptoms of COVID-19 or Influenza-like Disease

Who this might be right for
Influenza Viral InfectionsCOVID-19
China Medical University Hospital 170
Not applicableNot Yet RecruitingNCT07352462
What this trial is testing

Volatile Organic Compounds Analysis by GC-MS for Diagnostic of Hospitalised Patients With Respiratory Infections Using Exhaled Breath

Who this might be right for
Respiratory InfectionsCOVID-19Influenza Virus Infection+1 more
Hospices Civils de Lyon 777
Post-approval studies (Phase 4)Study completedNCT01248715
What this trial is testing

Rapid Empiric Treatment With Oseltamivir Study (RETOS)

Who this might be right for
InfluenzaPneumonia
University of Louisville 1,107
Early research (Phase 1)Study completedNCT05585632
What this trial is testing

A Safety, Reactogenicity, and Immunogenicity Study of mRNA-1045 (Influenza and Respiratory Syncytial Virus [RSV]) or mRNA-1230 (Influenza, RSV, and Severe Acute Respiratory Syndrome Coronavirus 2 [SARS-CoV-2]) Vaccine in Adults 50 to 75 Years Old

Who this might be right for
SARS-CoV-2InfluenzaRSV
ModernaTX, Inc. 392
Testing effectiveness (Phase 2)Study completedNCT05981846
What this trial is testing

A Phase II Trial to Evaluate the Safety and Immunogenicity of BIMERVAX® When Coadministered With Seasonal Influenza Vaccine (SIIV) in Adults Older Than 65 Years of Age Fully Vaccinated Against COVID-19

Who this might be right for
SARS CoV 2 InfectionInfluenza, Human
Hipra Scientific, S.L.U 279
Not applicableStudy completedNCT05866237
What this trial is testing

COVID-19 Vaccine Uptake Amongst Underserved Populations in East London

Who this might be right for
COVID-19InfluenzaVaccination Refusal
Queen Mary University of London 5,903
Large-scale testing (Phase 3)Looking for participantsNCT07604103
What this trial is testing

Analysis of Growth Differentiation Factor 15 (GDF-15), Mid Regional proAdrenomedullin (MR proADM), and Persepsin Levels in Patient in Acute Coronary Syndrome Patients With Pneumonia, With or Without Influenza Vaccination

Who this might be right for
Acute Coronary Syndromes (ACS)PneumoniaCOPD (Chronic Obstructive Pulmonary Disease)
University of Brawijaya 60
Next Page